ES2382664T3 - Famciclovir para el tratamiento de herpes labial recurrente usando un tratamiento de un día - Google Patents

Famciclovir para el tratamiento de herpes labial recurrente usando un tratamiento de un día Download PDF

Info

Publication number
ES2382664T3
ES2382664T3 ES06739956T ES06739956T ES2382664T3 ES 2382664 T3 ES2382664 T3 ES 2382664T3 ES 06739956 T ES06739956 T ES 06739956T ES 06739956 T ES06739956 T ES 06739956T ES 2382664 T3 ES2382664 T3 ES 2382664T3
Authority
ES
Spain
Prior art keywords
treatment
day
compound
lesions
famciclovir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06739956T
Other languages
English (en)
Spanish (es)
Inventor
Stephan Billstein
Robert Charnas
Spotswood L. Spruance
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH Austria
Novartis AG
Original Assignee
Novartis Pharma GmbH Austria
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma GmbH Austria, Novartis AG filed Critical Novartis Pharma GmbH Austria
Priority claimed from PCT/US2006/011498 external-priority patent/WO2006105216A1/en
Application granted granted Critical
Publication of ES2382664T3 publication Critical patent/ES2382664T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES06739956T 2005-03-30 2006-03-29 Famciclovir para el tratamiento de herpes labial recurrente usando un tratamiento de un día Active ES2382664T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66653605P 2005-03-30 2005-03-30
US666536P 2005-03-30
PCT/US2006/011498 WO2006105216A1 (en) 2005-03-30 2006-03-29 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment

Publications (1)

Publication Number Publication Date
ES2382664T3 true ES2382664T3 (es) 2012-06-12

Family

ID=36829888

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06739956T Active ES2382664T3 (es) 2005-03-30 2006-03-29 Famciclovir para el tratamiento de herpes labial recurrente usando un tratamiento de un día

Country Status (15)

Country Link
US (4) US20100298353A1 (enExample)
EP (2) EP2363131A1 (enExample)
JP (3) JP2008534603A (enExample)
KR (1) KR101312820B1 (enExample)
CN (1) CN101678028A (enExample)
AT (1) ATE545419T1 (enExample)
AU (3) AU2006230269A1 (enExample)
BR (1) BRPI0609793A2 (enExample)
CA (1) CA2602641A1 (enExample)
ES (1) ES2382664T3 (enExample)
PL (1) PL1865961T3 (enExample)
PT (1) PT1865961E (enExample)
RU (2) RU2007139762A (enExample)
TW (1) TW200716124A (enExample)
WO (1) WO2006105194A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
DE3671227D1 (de) 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
GB8628826D0 (en) 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
RU2179849C2 (ru) * 1999-07-27 2002-02-27 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Способ лечения рецидивирующего генитального герпеса у женщин
RU2178699C1 (ru) * 2001-04-04 2002-01-27 Змызгова Анна Васильевна Способ лечения герпесовирусных инфекций, включающий озонотерапию
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Also Published As

Publication number Publication date
AU2010201834A1 (en) 2010-05-27
US20100298353A1 (en) 2010-11-25
US20120329814A1 (en) 2012-12-27
JP2013049687A (ja) 2013-03-14
KR101312820B1 (ko) 2013-09-27
KR20080004535A (ko) 2008-01-09
JP2008534603A (ja) 2008-08-28
ATE545419T1 (de) 2012-03-15
RU2007139762A (ru) 2009-05-10
AU2006230291A8 (en) 2013-10-24
PL1865961T3 (pl) 2012-07-31
WO2006105194A2 (en) 2006-10-05
EP2363131A1 (en) 2011-09-07
EP1865961B1 (en) 2012-02-15
RU2007139758A (ru) 2009-05-10
WO2006105194A3 (en) 2006-12-21
RU2432951C2 (ru) 2011-11-10
BRPI0609793A2 (pt) 2010-04-27
JP2015163614A (ja) 2015-09-10
AU2006230269A1 (en) 2006-10-05
US20150005324A1 (en) 2015-01-01
AU2006230291A1 (en) 2006-10-05
TW200716124A (en) 2007-05-01
PT1865961E (pt) 2012-05-22
CA2602641A1 (en) 2006-10-05
JP6018473B2 (ja) 2016-11-02
CN101678028A (zh) 2010-03-24
US20120088781A1 (en) 2012-04-12
AU2010201834B2 (en) 2012-04-19
EP1865961A1 (en) 2007-12-19

Similar Documents

Publication Publication Date Title
Peterslund et al. Acyclovir in herpes zoster
Siegel Diagnosis and management of recurrent herpes simplex infections
ES2784240T3 (es) Composiciones farmacéuticas que comprenden DGLA y uso de las mismas
US20140221297A1 (en) Topical antiviral formulations
Levy et al. The effect of dosage form upon the gastrointestinal absorption rate of salicylates
ES3031213T3 (en) Treatment of warts
ES2382664T3 (es) Famciclovir para el tratamiento de herpes labial recurrente usando un tratamiento de un día
AU2010201836B2 (en) Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
Keservani et al. Chewing gum as a drug delivery system
US20120329815A1 (en) Famciclovir for the Treatment of Recurrent Herpes Labialis using a One-Day Treatment
JPH10513434A (ja) 治療後の神経痛の治療のためのペンシクロリンの使用
Case et al. The protective effect of lodoxamide on antigen-induced bronchospasm: An orally active antiallergic drug
Wachtel Major burns: What to do at the scene and en route to the hospital
El-Farrash et al. Allopurinol as a potential therapeutic agent for recurrent herpes labialis
TUCKER Nanoparticle Emulsion Speeds Cold Sore Healing
GB2282759A (en) Use of acyclovir in treatment of post-herpetic neuralgia
Rajamannan Próximo pago de haberes
KIRN ACL Reconstruction Called Safe in Kids, Teens